Galera Therapeutics GRTX

$ 0.14 -32.59%

Quarterly report 2024-Q2
added 08-14-2024

Galera Therapeutics Balance Sheet 2011-2024 | GRTX

Annual Balance Sheet Galera Therapeutics

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-19.8 M	-15.3 M	-17.5 M	-14.8 M	-6.17 M	-	-	-	-	-	-
Long Term Debt	1.12 M	-	44 K	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	64 M	44.1 M	186 M	90.7 M	-	-	-	-	-	-
Total Current Liabilities	4.96 M	13.4 M	12.9 M	14 M	9.69 M	-	-	-	-	-	-	-	-
Total Liabilities	157 M	153 M	141 M	78 M	53.8 M	193 M	95 M	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-437 M	-378 M	-316 M	-236 M	-161 M	-105 M	-76.1 M	-	-	-	-	-	-
Total Assets	26.1 M	44 M	83.3 M	84.1 M	123 M	88.1 M	18.9 M	-	-	-	-	-	-
Cash and Cash Equivalents	18.3 M	4.27 M	19.9 M	15.9 M	18.4 M	14.8 M	-	-	-	-	-	-	-
Book Value	-131 M	-109 M	-58 M	6.12 M	69.6 M	-105 M	-76.1 M	-	-	-	-	-	-
Total Shareholders Equity	-131 M	-109 M	-58 M	6.12 M	69.6 M	-105 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Galera Therapeutics

	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	1.04 M	1.08 M	1.12 M	1.16 M	1.19 M	-	-	-	-	-	44 K	110 K	172 K	235 K	296 K	296 K	296 K	296 K	534 K	534 K	534 K	534 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	154 M	154 M	157 M	164 M	163 M	157 M	153 M	148 M	144 M	142 M	141 M	142 M	141 M	81.1 M	78 M	78 M	78 M	78 M	53.8 M	53.8 M	53.8 M	53.8 M	27 M	27 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-446 M	-442 M	-437 M	-432 M	-417 M	-396 M	-378 M	-362 M	-346 M	-332 M	-316 M	-299 M	-277 M	-254 M	-236 M	-236 M	-236 M	-236 M	-161 M	-161 M	-161 M	-161 M	-105 M	-105 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	16.4 M	19.7 M	26.1 M	37.8 M	48.3 M	59.7 M	44 M	50.7 M	61.1 M	71.1 M	83.3 M	98.8 M	115 M	70.5 M	84.1 M	84.1 M	84.1 M	84.1 M	123 M	123 M	123 M	123 M	88.1 M	88.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	10.7 M	13.5 M	18.3 M	24.4 M	24.4 M	25.7 M	4.27 M	12.8 M	17.4 M	19.6 M	19.9 M	17.6 M	38.5 M	13.7 M	15.9 M	15.9 M	15.9 M	15.9 M	18.4 M	18.4 M	18.4 M	18.4 M	14.8 M	14.8 M	-	-	6.17 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-138 M	-135 M	-131 M	-127 M	-115 M	-97.6 M	-109 M	-97.5 M	-83.2 M	-70.5 M	-58 M	-43.2 M	-25.5 M	-10.6 M	6.12 M	6.12 M	6.12 M	6.12 M	69.6 M	69.6 M	69.6 M	69.6 M	61.1 M	61.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-138 M	-135 M	-131 M	-127 M	-115 M	-97.6 M	-109 M	-97.5 M	-83.2 M	-70.5 M	-58 M	-43.2 M	-25.5 M	-10.6 M	6.12 M	6.12 M	6.12 M	6.12 M	69.6 M	69.6 M	69.6 M	69.6 M	-105 M	-105 M	-87.9 M	-82.6 M	-76.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency